Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Coronaviruses
  4. Fast Track Articles
  5. Fast Track Article
image of Antimicrobial Susceptibility Profile of Bacteria Isolated from Hemocultures of Patients Attended in a Campaign Hospital During COVID-19 Pandemic

Abstract

Introduction

Primary bloodstream infections are most commonly related to health care and are associated with intravascular devices, increasing patient mortality, length of stay, and health care costs. Among the complications of hospitalizations for COVID-19, bloodstream infection is one of the most prevalent, requiring prevention and early treatment. Due to the contingency of hospital resources during the pandemic, understanding the prevalence and incidence of antimicrobial agents that cause bloodstream infections and using exams judiciously are essential public health measures, avoiding the misuse of antimicrobials and being able to establish treatment.

Objective

This study aimed to determine the antimicrobial susceptibility profile and the prevalence of etiological agents of bloodstream infections in patients with COVID-19 at the field hospital in the city of São Bernardo do Campo - SP.

Method

A descriptive, observational, and retrospective cross-sectional study was carried out on the results of blood cultures already collected for diagnostic purposes from patients from May to August 2020 at the same hospital.

Results

Of the 300 blood cultures analyzed, 73.7% of the samples showed no bacterial growth. Among the others, the main bacteria found were sensitive to tigecycline, present in 30 (10%), followed by (coagulase-negative, non-lugdunensis), sensitive only to doxycycline, gentamicin, tetracycline, and vancomycin, in only 2 (14.3%) samples.

Conclusion

In this study, a low rate of laboratory-confirmed bacterial coinfection was identified in patients with COVID-19.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975286863241028050424
2024-10-04
2025-03-01

  • From This Site

    /content/journals/covid/10.2174/0126667975286863241028050424
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Prevention of primary bloodstream infection related to central vascular access. 2014 Available from: https://hcrp.usp.br/revistaqualidadehc/uploads/Artigos/470/470.pdf
  2. Manual of health care-related infection prevention measures. 2013 Available from: https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/publicacoes/caderno-4-medidas-de-prevencao-de-infeccao-relacionada-a-assistencia-a-saude.pdf/view
  3. National Health Surveillance Agency. 2010 Available from: https://www.saudedireta.com.br/docsupload/1340372157manual_orientacao_prevencao_ics_set_2010_anvisa.pdf
  4. Wordometer. COVID-19 coronavirus pandemic. 2020 Available from:https://www.worldometers.info/coronavirus/
  5. He Y. Li W. Wang Z. Chen H. Tian L. Liu D. Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China. Infec. Control Hosp. Epidem. 2020 41 8 982 983
    [Google Scholar]
  6. Guan W. Ni Z. Hu Y. Liang W. Ou C. He J. Liu L. Shan H. Lei C. Hui D.S.C. Du B. Li L. Zeng G. Yuen K.Y. Chen R. Tang C. Wang T. Chen P. Xiang J. Li S. Wang J. Liang Z. Peng Y. Wei L. Liu Y. Hu Y. Peng P. Wang J. Liu J. Chen Z. Li G. Zheng Z. Qiu S. Luo J. Ye C. Zhu S. Zhong N. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 382 18 1708 1720 10.1056/NEJMoa2002032 32109013
    [Google Scholar]
  7. Zhang J. Dong X. Cao Y. Yuan Y. Yang Y. Yan Y. Akdis C.A. Gao Y. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy 2020 75 7 1730 1741 10.1111/all.14238 32077115
    [Google Scholar]
  8. Wan Y. Shang J. Graham R. Baric R.S. Li F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 2020 94 7 e00127-20 10.1128/JVI.00127‑20 31996437
    [Google Scholar]
  9. Ventoulis I. Sarmourli T. Amoiridou P. Mantzana P. Exindari M. Gioula G. Vyzantiadis T.A. Bloodstream infection by Saccharomyces cerevisiae in two COVID-19 patients after receiving supplementation of Saccharomyces in the ICU. J. Fungi 2020 6 3 98 10.3390/jof6030098 32630111
    [Google Scholar]
  10. Sepulveda J. Westblade L.F. Whittier S. Satlin M.J. Greendyke W.G. Aaron J.G. Zucker J. Dietz D. Sobieszczyk M. Choi J.J. Liu D. Russell S. Connelly C. Green D.A. Bacteremia and blood culture utilization during COVID-19 surge in New York City. J. Clin. Microbiol. 2020 58 8 e00875-20 10.1128/JCM.00875‑20 32404482
    [Google Scholar]
  11. Langford B.J. Soucy J.P. Leung V. So M. Kwan A.T. Portnoff J.S. Bertagnolio S. Raybardhan S. MacFadden D.R. Daneman N. Antibiotic resistance associated with the COVID-19 pandemic: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2023 29 3 302 309 10.1016/j.cmi.2022.12.006 36509377
    [Google Scholar]
  12. Mędrzycka-Dąbrowska W. Lange S. Zorena K. Dąbrowski S. Ozga D. Tomaszek L. Carbapenem-resistant Klebsiella pneumoniae infections in ICU COVID-19 patients—A scoping review. J. Clin. Med. 2021 10 10 2067 10.3390/jcm10102067 34066031
    [Google Scholar]
  13. Arcari G. Raponi G. Sacco F. Bibbolino G. Di Lella F.M. Alessandri F. Coletti M. Trancassini M. Deales A. Pugliese F. Antonelli G. Carattoli A. Klebsiella pneumoniae infections in COVID-19 patients: A 2-month retrospective analysis in an Italian hospital. Int. J. Antimicrob. Agents 2021 57 1 106245 10.1016/j.ijantimicag.2020.106245 33253903
    [Google Scholar]
  14. Sola M.C. Oliveira A. Feistel J. Rezende C. Maintenance of microorganisms: Conservation and viability. Biosphere Encycl 2012 8 14
    [Google Scholar]
  15. Falagas M.E. Karveli E.A. Kelesidis I. Kelesidis T. Community-acquired Acinetobacter infections. Eur. J. Clin. Microbiol. Infect. Dis. 2007 26 12 857 868 10.1007/s10096‑007‑0365‑6 17701432
    [Google Scholar]
  16. Lima A.L. Oliveira P.R. Paula A.P. Acinetobacter infection. N. Engl. J. Med. 2008 358 26 2846 2847 18584823
    [Google Scholar]
  17. Huertas Vaquero M. Asencio Egea M.Á. Carranza González R. Padilla Serrano A. Conde García M.C. Tenias Burillo J.M. Redondo González O. Association between antibiotic pressure and the risk of colonization/infection by multidrug-resistant Acinetobacter baumannii complex: A time series analysis. Rev. Esp. Quimioter. 2021 34 6 623 630 10.37201/req/061.2021 34610732
    [Google Scholar]
  18. Mak J.K. Kim M.J. Pham J. Tapsall J. White P.A. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 2009 63 1 47 54 10.1093/jac/dkn454 18988680
    [Google Scholar]
  19. Reina R. León-Moya C. Garnacho-Montero J. Treatment of serious Acinetobacter baumannii infections. Med. Intensiva 2022 46 12 700 710 10.1016/j.medin.2022.08.003 36272902
    [Google Scholar]
  20. Monnet D.L. Harbarth S. Will coronavirus disease (COVID-19) impact antimicrobial resistance? Euro 2020 Surveillance Tour 2020
    [Google Scholar]
  21. European Center for Disease Prevention and Control (ECDC). 2019 Available from:https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2018
  22. Montrucchio G. Corcione S. Sales G. Curtoni A. De Rosa F.G. Brazzi L. Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball. J. Glob. Antimicrob. Resist. 2020 23 398 400 10.1016/j.jgar.2020.11.004 33242674
    [Google Scholar]
  23. Pons M.J. Marí-Almirall M. Ymaña B. Moya-Salazar J. Muñoz L. Sauñe S. Salazar-Hernández R. Vila J. Roca I. Spread of ST348 Klebsiella pneumoniae producing NDM-1 in a Peruvian hospital. Microorganisms 2020 8 9 1392 10.3390/microorganisms8091392 32932763
    [Google Scholar]
  24. Sacsaquispe-Contreras R. Bailón-Calderón H. Identification of carbapenem-resistant genes in enterobacteria from peruvian hospitals, 2013-2017. Rev. Peru. Med. Exp. Salud Publica 2018 35 2 259 264 10.17843/rpmesp.2018.352.3829 30183920
    [Google Scholar]
  25. Arteaga-Livias K. Pinzas-Acosta K. Perez-Abad L. Panduro-Correa V. Rabaan A.A. Pecho-Silva S. Dámaso-Mata B. A multidrug-resistant Klebsiella pneumoniae outbreak in a Peruvian hospital: Another threat from the COVID-19 pandemic. Infect. Control Hosp. Epidemiol. 2022 43 2 267 268 10.1017/ice.2020.1401 33397537
    [Google Scholar]
  26. Annavajhala M.K. Mohri H. Wang P. Nair M. Zucker J.E. Sheng Z. A novel and expanding SARS-CoV-2 variant, B. 1.526, identified in New York. MedRxiv 2021 2021
    [Google Scholar]
  27. García-Meniño I. Forcelledo L. Rosete Y. García-Prieto E. Escudero D. Fernández J. Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm. J. Infect. Public Health 2021 14 1 50 52 10.1016/j.jiph.2020.11.001 33341484
    [Google Scholar]
  28. Tri B. Antimicrobial Stewardship, COVID-19, and Infection Control Program: Spread of Carbapenem-Resistant Klebsiella pneumoniae Colonization in COVID-19 ICU Patients. What didn't work? J. Clinical Med. 2020 9 9 2744
    [Google Scholar]
  29. Hosoda T. Harada S. Okamoto K. Ishino S. Kaneko M. Suzuki M. Ito R. Mizoguchi M. COVID-19 and fatal sepsis caused by hypervirulent Klebsiella pneumoniae, Japan, 2020. Emerg. Infect. Dis. 2021 27 2 556 559 10.3201/eid2702.204662 33320080
    [Google Scholar]
  30. Sinto R. Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in Indonesia's national referral hospital. Antimicrob Resist Infect Control 2022 11 1 1 12
    [Google Scholar]
  31. Edrada E.M. Lopez E.B. Villarama J.B. Salva Villarama E.P. Dagoc B.F. Smith C. Sayo A.R. Verona J.A. Trifalgar-Arches J. Lazaro J. Balinas E.G. Telan E.F. Roy L. Galon M. Florida C.H. Ukawa T. Villanueva A.M. Saito N. Nepomuceno J.R. Ariyoshi K. Carlos C. Nicolasora A.D. Solante R.M. First COVID-19 infections in the Philippines: A case report. Trop. Med. Health 2020 48 1 21 10.1186/s41182‑020‑00203‑0
    [Google Scholar]
  32. Chagas A.P. Lima V.P. Rapid insertion and dissemination of bacterial resistance in a covid unit and the impact on empirical antimicrobial treatment of patients with bacteremia. Braz. J. Infect. Dis. 2022 26 102647 10.1016/j.bjid.2022.102647
    [Google Scholar]
  33. Da Silva David M.T. The impact of indiscriminate use of antibiotics in the COVID-19 pandemic. 2021
    [Google Scholar]
  34. Dias M.L. Correal J.C. de Moura C.A. Ledesma L.A. Oliveira L.T. Araújo S.M. Reetz R.B. Ferreira H.H. Damasco P.V. Descriptive analysis of positivity and contamination rates of blood cultures performed in eight private tertiary hospitals in Rio de Janeiro in 2021 in the COVID-19 era. Braz. J. Infect. Dis. 2022 26 102229 10.1016/j.bjid.2021.102229
    [Google Scholar]
  35. Pimentel N.V. Factors associated with colonization by methicillin-resistant Staphylococcus aureus in patients with COVID-19 in intensive care. Rev. Bras. Enferm. 2023 73 6 e20190483
    [Google Scholar]
/content/journals/covid/10.2174/0126667975286863241028050424
Loading
Antimicrobial Susceptibility Profile of Bacteria Isolated from Hemocultures of Patients Attended in a Campaign Hospital During COVID-19 Pandemic
Bentham Science Publishers ; https://doi.org/10.2174/0126667975286863241028050424
/content/journals/covid/10.2174/0126667975286863241028050424
/content/journals/covid/10.2174/0126667975286863241028050424
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: bacterial resistance to antimicrobials ; COVID-19 ; Coronavirus infections ; bloodstream infection ; health care-related infection (HAI) ; hospital infection
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test